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The Expression Pattern of Epstein-Barr Virus
Latent Genes In Vivo Is Dependent upon the
Differentiation Stage of the Infected B Cell
quiescent state, why does it possess a latency mecha-
nism, the growth program, that places the host at risk
of developing life-threatening neoplasias? The simplest
explanation is that EBV infects resting B cells directly
in vivo and remains quiescent. Any infected cells that
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express the growth program would be eliminated by
CTL, explaining why the virus is only detected in resting
B cells. This explanation is unsatisfactory for a numberSummary
of reasons. First, there is no evidence that an EBV-
infected resting B cell can stay resting. All of the in vitroEpstein-Barr virus–infected B cells in vivo demon-
studies suggest that EBV is poised to initiate the growthstrate three distinct patterns of latent gene expres-
program when it infects a resting B cell. Second, it doession, depending on the differentiation stage of the cell.
not explain why the virus is restricted to memory cells.Tonsillar naive B cells express the EBNA2-dependent
Third, this model offers no explanation for the existencelymphoblastoid phenotype, characteristic of direct in-
of the growth program.fection. Germinal center centroblasts and centrocytes
We assume that the growth program is in some wayas well as tonsillar memory B cells express a more
essential for establishing and/or maintaining the persis-restricted pattern of latent genes (EBNA1(Q-K)1,
tent infection. If it was not essential, evolutionary pres-LMP11, LMP21, EBNA22) that has only been seen pre-
sure would have eliminated it because it is potentiallyviously in EBV-positive tumors. Peripheral memory
detrimental to the host. In what way could the growthcells express an even more restricted pattern where
program be essential? One possibility is that it providesno latent genes are expressed, with the possible ex-
a mechanism to replicate and spread the virus. Replica-ception of LMP2. These results are consistent with a
tion is unlikely, since viraemia will produce much moremodel where EBV uses the normal biology of B lym-
virus more quickly than dividing cells. Spreading thephocytes to gain access to and persist within the long-
virus is more likely because latently infected B cells maylived memory B cell compartment.
be able to distribute the virus to all of the lymphoid
tissues to establish a disseminated persistent infection.Introduction
The difficulty is that a mechanism is required that allows
the latently infected proliferating lymphoblasts, ex-Epstein-Barr virus is a B lymphotropic human herpesvi-
pressing the growth program, to exit the cell cycle andrus. The virus persists in the peripheral blood in a very
become resting, and this mechanism must only applyspecific subset, the resting memory B cell (Miyashita et
to infected memory cells to account for the restrictional., 1997; Babcock et al., 1998). These cells express little
of EBV to resting memory cells in the periphery. Toor no viral genetic information (Qu and Rowe, 1992;
resolve this issue, we have turned to normal B cell biol-Babcock et al., 1999)—a condition we have referred to as
ogy. We have proposed (Thorley-Lawson and Babcock,the “latency program” (Thorley-Lawson and Miyashita,
1999) that the growth program is essential for the estab-1996). As such, they constitute no pathologic threat and
lishment of latency because it allows the latently in-may be invisible to the host’s immune system. This be-
fected B cells to differentiate into resting memory Bhavior contrasts with the events seen in newly infected
cells. In this model, the EBV-activated lymphoblast,B cells in vitro. In this case, the virus has no subset
driven by the growth program, is equivalent to a normal
preference but indiscriminately infects any B cell and
antigen-activated B cell blast, which can differentiate
drives it to become an activated lymphoblast through
into a resting memory cell through the process of germi-
the concerted expression of a set of latent genes under nal center formation (reviewed in MacLennan, 1994; Liu
the regulation of the transcription factor EBNA2 (re- and Arpin, 1997). In this process, antigen activates B
viewed in Kieff, 1996). The latent genes encode six nu- cells to become blasts that enter primary follicles, prolif-
clear antigens (EBNAs) and three membrane proteins erate, and alter their Ig genes through isotype switching
(LMPs). We have referred to this as the “growth pro- and hypermutation. At intervals, these centroblasts stop
gram” (Thorley-Lawson and Miyashita, 1996) because dividing and become centrocytes. If cognate antigen
the latently infected blasts are highly proliferative. As and T cell help are available, the cells will again prolifer-
such, they are potentially dangerous for the host, but ate, if not, they die. Eventually, the cells exit the cell cycle
they are also strongly immunogenic and are readily rec- either by becoming antibody-secreting plasma cells or,
ognized and controlled by cytotoxic T cells (reviewed as antigen begins to wane, memory cells.
in Khanna et al., 1995). We have proposed that EBV infects normal resting
These observations lead to two critical questions. B cells in the lymphoid tissue and drives them to be-
First, how does a potent growth-promoting virus achieve come proliferating blasts through the EBNA2-dependent
the quiescent state observed in the resting peripheral growth program. It does this to activate them so they can
memory cells? Second, if the virus can persist in this then differentiate through a germinal center. Latently
infected cells could survive germinal center selection
by expressing the latent proteins LMP1 and LMP2.* To whom correspondence should be addressed (e-mail: dlawson@
opal.tufts.edu). LMP1 can, in a ligand-independent fashion, mimic the
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signal generated by CD40 (Gires et al., 1997) on the B
cell when it interacts with an antigen-specific T helper
(Th) cell. Similarly, LMP2 can, in a ligand-independent
fashion, mimic the rescue signal delivered by the antigen
receptor (Caldwell et al., 1998). Thus, LMP1 and LMP2
have the potential to provide the necessary signals, in-
dependent of real antigen and T cell help, to allow la-
tently infected cells, which have entered the germinal
center, to survive and differentiate into memory cells.
Evidence to support this idea comes from studies sug-
gesting that the EBV-associated tumor Hodgkin’s dis-
ease (HD) originates from a germinal center or memory
B cell (Kuppers and Rajewsky, 1998) and only expresses
EBNA1, LMP1, and LMP2 (Pallesen et al., 1991; Oude-
jans et al., 1996; Niedobitek et al., 1997) . These genes
are expressed in an EBNA2-independent way that, in
the case of EBNA1, involves the use of a unique pro-
moter, Qp (Schaefer et al., 1995; Tsai et al., 1995; Non-
kwelo et al., 1996).
If EBV is using the normal pathways of B cell activation
and differentiation to gain access to the memory com-
partment, then the important intermediate steps in per-
sistence should, as with antigen-driven activation/differ-
entiation, be occurring in the secondary lymphoid tissue
not in the peripheral circulation. The tonsil is a known Figure 1. EBV Is Present in All the Major B Cell Subsets Found in
the Tonsilsite of viral persistence with both latently infected cells
and viral replication (Babcock et al., 1998) and is readily (A) Germinal center, memory and naive B cells contain EBV. Naive
(IgD1), germinal center (CD101), and memory B cells were purifiedavailable for study. Therefore, to test the ideas dis-
as detailed in Experimental Procedures. The purified populationscussed above, we have analyzed the status of EBV infec-
were costained for the pan-B cell marker CD20 for reanalysis to
tion in specific subsets of B cells from the tonsil. To do check purity. The cells were subjected to limiting dilution DNA PCR
this, we have taken advantage of a series of elegant analysis. In this technique, cell populations are serially diluted and
studies (reviewed in Liu and Arpin, 1997) establishing then multiple samples of each dilution tested for the presence of
EBV with a DNA PCR assay that can detect a single copy of thethat specific cell surface markers can be used to identify
viral genome. By applying Poisson statistics, the absolute frequencyand isolate functionally distinct subsets of human B cells
of virus-infected cells can then be calculated. Southern blot analysisfrom the tonsil.
of the PCR products is shown. Note that the sample in any given
lane is not a direct dilution of the sample directly above it but a
replicate of samples with the same cell number. N.B., We have
shown previously that all CD191 B cells in the tonsil, that carry EBV,Results
are latently infected (Babcock et al., 1998).
(B) Germinal center, centroblasts and centrocytes contain EBV. Na-EBV-Infected Cells Are Present in All Tonsillar
ive B cells and germinal center centroblasts (CD771, CD101) and
B Cell Subsets centrocytes (CD772, CD101) were isolated as described in Experi-
If EBV is using the germinal center to gain access to mental Procedures. PCR and FACS analysis were as described
the memory compartment, then there should be latently in (A).
infected germinal center cells in the tonsil. We have
shown previously that tonsils contain infected naive are shown in Figure 1A. This experiment was repeated
(IgD1) and IgD2 B cells (Babcock et al., 1998) and that the on eight tonsils, and representative results from three
cells are latently infected (Decker et al., 1996). However, tonsils (numbers one through three) are summarized in
IgD2 cells in the tonsil are a mixture of both germinal Table 1. In all cases, significant numbers of infected
center cells and memory cells. To test if both are in- cells were found in all three populations of cells tested.
fected, we separated the IgD2 B cell fraction into germi- FACS analysis of the purified populations from one ex-
nal center and memory populations, based on the ex- periment is also shown in Figure 1A. The populations
pression of the germinal center–specific marker CD10 were always $90% pure and contaminated with #5%
(Pascual et al., 1994). The frequency of virus-infected of other B cell subsets. The remaining contamination
cells in each population was then estimated using a consisted of T cells, which lack EBV and are therefore
modified version of the limiting dilution DNA PCR irrelevant to the analysis. Based on these results, we
method described previously (Babcock et al., 1998). In conclude that the naive, germinal center, and memory
this technique, cell populations are serially diluted, and B cell subsets all contain cells latently infected with
then multiple samples of each dilution are tested for the EBV and that the presence of these cells cannot be
presence of EBV with a DNA PCR assay that can detect accounted for by cross-contamination with other B cell
a single copy of the viral genome. By applying Poisson subsets.
statistics, the absolute frequency of virus-infected cells A similar study was performed for the germinal center
subsets. In this case, the IgD2 B cells were stained forcan then be calculated. The results of one such analysis
Differential EBV Latent Gene Expression in Tonsils
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Table 1. Frequency of EBV-Infected Cells in the Tonsillar Memory B Cell Compartment
Number of Infected Cells/107 Total Cells
Tonsil Naive Memory Germinal Center Centroblasts Centrocytes
1 50 25 70 2 2
2a 270 1000 300 415 500
3a 75 100 40 200 70
4 70 2 2 35 140
5 ,20 140 ,20 2 2
6 ,20 800 ,20 2 2
7 ,20 .800 ,20 ,20 ,20
N.B., Tonsils five to seven were the only three analyzed that lacked infected naive cells, whereas tonsils one to four are representative of a
larger panel of 13 tonsils that demonstrated similar results.
a Fractionations into memory versus germinal center and memory versus centroblasts and centrocytes were performed on separate occasions.
CD10 and CD77 and fractionated into the centroblasts viously defined in vitro (lymphoblastoid growth program)
or in tumor models (HD/NPC). Figure 2A shows the anal-(CD101, CD771) and centrocytes (CD101, CD772) (Pas-
ysis from one tonsil. Both the germinal center (IgD2,cual et al., 1994; Liu and Arpin, 1997). An example of
CD101) and memory (IgD2, CD102) populations ex-one such experiment is shown in Figure 1B. A total of
pressed EBNA1(Q-K), but it was not detected in theseven tonsils were tested altogether with similar results,
naive (IgD1) population. Conversely, EBNA2 was onlyand the quantitative results from three representative
expressed in the naive population. All three subsetstonsils (numbers two through four) are shown in Table
expressed LMP1 and LMP2. Figure 2B shows the results1. Both germinal center subsets had significant levels
for two tonsils that were fractionated in parallel intoof virus-infected cells that could not be accounted for
either naive or memory populations, and the same re-by cross-contamination.
sults were observed: EBNA2 was only found in the naiveWe conclude, therefore, that tonsils with infected na-
subset and EBNA1(Q-K) only in the memory subset.ive cells also contain infected memory cells and germi-
Most of our experiments were performed on memorynal center cells, including both centroblasts and cen-
cells defined as CD32, IgD2, CD102. It was conceivabletrocytes.
that the cells were not truly memory cells but were aber-
rant sIg2 B cells. Therefore, we performed a limitingViral Gene Expression in Tonsillar B Cell Subsets
dilution DNA PCR and an RT-PCR analysis on memoryWe have shown previously that viral replication is ongo-
cells that were positively selected for sIg as the last steping in the tonsil (Babcock et al., 1998). Therefore, the
in the purification. All of the virus-infected cells in thesimplest interpretation of our DNA PCR analysis is that
CD32, IgD2, CD102 population fractionated into the sIg1all B cell subsets are being directly infected in the tonsil
subset, and the viral gene expression pattern was found
and should express the EBNA2-dependent growth pro-
to be identical to the unselected CD32, IgD2, CD102
gram. However, our model predicts that latently infected
cells (data not shown).
germinal center and memory cells are not derived Lastly, germinal center cells were isolated from six
through direct infection but by differentiation of directly tonsils and separated into centroblasts (CD771) and
infected B lymphoblasts. In this scenario, the infected centrocytes (CD772). The RT-PCR analysis for these
germinal center population should not express the samples is shown in Figure 2C. EBNA2 was never de-
EBNA2-dependent form of latency but a restricted la- tected in either population from any of the six tonsils,
tency such as is found in EBV-positive HD. To distinguish whereas EBNA1(Q-K) was found in centroblasts from
these two possibilities, we have performed RT-PCR 6/6 tonsils and in centrocytes from 3/6 tonsils. LMP1
analysis on the isolated tonsillar B cell subsets. Since was found in both populations from all of the tonsils
we wanted to analyze multiple genes on the same sam- studied and LMP2a in centroblasts and centrocytes
ples, we selected diagnostic genes to test. Specifically, from 5/6 tonsils. These results are in agreement with
we chose EBNA2 as a marker for the growth program those obtained for whole unfractionated germinal center
that drives the lymphoblastoid form of latency character- cells shown in Figure 2A.
istic of directly infected cells. We choose EBNA1(Q-K) to When we last studied peripheral blood, the only latent
represent the restricted forms of latency and LMP1 plus gene we found to be expressed was LMP2. However,
LMP2 to distinguish the BL form (EBNA1(Q-K) only) from since that time, we have increased the sensitivity of our
the HD/NPC form (EBNA1(Q-K) plus LMP1 and LMP2a). RT-PCR assays to the point where we routinely detect
We have analyzed naive (IgD1), germinal center (IgD2, all four transcripts upon RT-PCR of a single infected
CD101), centroblast (IgD2, CD101, CD771), centrocyte cell in the presence of 2 3 106 EBV-negative tonsil cells.
(IgD2, CD101, CD772), and memory populations (IgD2, This is demonstrated in Figure 3B, which shows an ex-
CD102) from 17 tonsils, although not every subset was ample of the sensitivity titration and multiple negative
always tested for every tonsil. Representative examples controls that were performed with each experiment. It
are shown in Figure 2, and a summary of all the results is was conceivable that the more complex patterns of gene
shown in Table 2. It is apparent that, unlike the peripheral expression we now report in the tonsil, compared to our
blood, latent gene expression was readily and reproduc- previous peripheral blood studies, simply reflected this
increased sensitivity. To check this, we performed RT-ibly detected in tonsillar subsets and in patterns pre-
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Figure 2. RT-PCR Analysis for Latent Gene
Expression in Tonsillar B Cell Subsets
(A) B cells from a single tonsil were frac-
tionated into naive (IgD1), germinal center
(CD101 IgD2), and memory (CD102, IgD2)
subsets as described in Experimental Proce-
dures. The cells were assayed for expression
of the latent transcripts EBNA1(Q-K), EBNA2,
LMP1, and LMP2a.
(B) As (A), except only naive and memory cells
from two different tonsils are shown.
(C) As (A), except only germinal center
centroblasts and centrocytes from six differ-
ent tonsils are shown.
(D) As (A), except only memory cells from two
peripheral blood samples are shown.
(E) As (A), except the subsets were first puri-
fied from an EBV-negative tonsil and then in-
fected in vitro for 48 hr with the B95-8 strain
of EBV.
Southern blot analysis of the PCR products
is shown. The expected size of the PCR product is indicated by an arrow to the left. Note that a band larger than the expected PCR product
was sometimes seen in the EBNA2 RT-PCR. This represents the unspliced sequence derived from contaminating genomic DNA.
PCR analysis on peripheral memory cells from two do- ments revealed (Figure 2E) that naive, germinal center,
and memory populations all expressed the EBNA21,nors (Figure 2D) and confirmed again that even with the
more sensitive assays we only detected LMP2a. LMP11, LMP21 phenotype expected of the lymphoblas-
toid growth program form of latency found in newlyOf the 11 tonsils (Table 2) and two peripheral blood sam-
ples studied, only the tonsil naive populations expressed infected cells. No hint of EBNA1(Q-K)2 activity was de-
tected. It is conceivable that direct infection of B cellthe latent gene pattern (EBNA21, LMP11, LMP2a1,
EBNA(Q-K)2) characteristic of the lymphoblastoid la- subsets, such as germinal center B cells, in special mi-
croenvironments in vivo could cause them to go directlytency that occurs after direct infection. EBNA1(Q-K)
was never detected in the tonsil naive population, in- to a EBNA1(Q-K)1, EBNA22 type of latency; however, the
simplest interpretation of our results is that the restricteddicating that it does not contain a mixture of cells ex-
pressing the restricted and lymphoblastoid forms of la- latency seen in the IgD2 subsets does not arise from
direct infection and must, therefore, arise through thetency. Whole germinal center cells, germinal center cells
separated into centroblasts and centrocytes, and mem- differentiation of newly infected cells.
ory cells never expressed detectable EBNA2. They all
expressed the limited form of latent gene expression The Viral Latent Gene Expression Patterns Are Not
previously only found in tumors such as HD and NPC Due to Cross-Contamination of Purified Subsets
(EBNA22, EBNA1(Q-K)1, LMP11, LMP21). EBNA1(Q-K) One issue that arises from the RT-PCR analysis is
expression (characteristic of BL) was never detected in whether the signals seen are representative of a subset
the absence of LMP1 and LMP2. Therefore, we were or are a consequence of contamination with other cell
unable to confirm the existence of an “EBNA1(Q-K) only” types. This is not of concern for the naive population. The
form of persistent infection. presence of EBNA2 and the absence of EBNA1(Q-K)
indicates no significant cross-contamination, because
all other subsets express EBNA1(Q-K) and lack EBNA2.Germinal Center and Tonsillar Memory Cells Express
the Lymphoblastoid Transcription Pattern, Not Similarly, we can be confident about the memory subset
since, for rare tonsils, this was the only subset infectedRestricted Latency, upon Direct Infection In Vitro
It is our interpretation that the EBNA1(Q-K)1, EBNA22 (see below). Analysis of gene expression in one such
tonsil revealed the same pattern of gene expressionphenotype of the IgD2 subsets had to arise through the
differentiation of a directly infected cell because all cells (EBNA22, EBNA1(Q-K)1, LMP11, LMP21) as memory
cells from other tonsils (data not shown). The majordirectly infected with EBV express the EBNA21 lympho-
blastoid form of latency. However, it was conceivable contamination issue concerns the germinal center pop-
ulations. Specifically, are the cells truly expressingthat the EBNA1(Q-K)1, EBNA22 phenotype was the nat-
ural phenotype of directly infected tonsillar germinal EBNA1(Q-K), LMP1, and LMP2, or is this the result of
cross-contamination with memory cells? To attempt tocenter and memory B cells. To prove that this was not
the case, we have isolated all three B cell subsets from address this question, memory, centroblast, and centro-
cyte populations were isolated from a single tonsil.an EBV-negative tonsil and infected them in vitro with
the B95-8 laboratory strain of virus. The cells were ana- FACS analysis of the populations are shown in Figure
3C. For the centroblasts and centrocytes, contaminatinglyzed by RT-PCR at 48 hr postinfection. This was before
proliferation had started and eliminates the possibility memory cells would reside in the bottom left-hand quad-
rant of the FACS dot plot. Since contaminating T cellsthat lymphoblastoid cells could have overgrown cells
expressing the restricted phenotype. These experi- also reside in this quadrant, we can conclude that there
Differential EBV Latent Gene Expression in Tonsils
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Table 2. EBV Latent Gene Expression in Tonsillar B Cell Subsets of All Tonsils Testeda
Population EBNA2 EBNA1(Q-K) LMP1 LMP2a
IgD1 naive 8/11 0/10 8/8 9/11
IgD2 germinal center and memory 0/2 2/2 2/2 2/2
IgD2 CD101 germinal center (GC) 0/1 1/1 1/1 1/1
IgD2 CD101 CD771 GC centroblasts 0/6 6/6 6/6 5/6
IgD2 CD101 CD772 GC centrocytes 0/6 3/6 6/6 5/6
IgD2 CD102 memory-tonsil 0/6 5/6 6/6 5/6
IgD2 memory-peripheral blood 0/2 0/2 0/2 2/2
a In all, 17 tonsils were analyzed. Not all genes were tested for all tonsils.
was 5% contamination with memory B cells in the evidence of viral replication, and, in these cases, we
also found no infected naive (IgD1) B cells (Babcock etcentroblast and centrocyte populations. Serial dilutions
of the same cells were then performed (Figure 3A) on al., 1998). This was not because the virus replicates in
the IgD1 cells. Viral replication in the tonsil is restrictedall three subsets to determine the endpoint of detection
by RT-PCR of the latent genes. As expected, EBNA2 to cells with an IgD2, CD192 phenotype (Babcock et al.,
1998). This led to the suggestion that naive B cells arewas not detected in any of the samples. The signals for
the other three genes titrated to points where it was being directly infected, a conclusion supported by the
RT-PCR analysis discussed above. Our model predictspossible to conclude that the centroblasts and centro-
cytes would have to have been massively contaminated, that these infected naive cells should differentiate into
germinal center cells. It follows that in a tonsil that lacksaround 50%, with memory cells to account for the RT-
PCR results seen. For example, the lowest dilution where viral replication and infected naive cells there should be
no infected germinal center cells either. We have beenLMP1 was detected was 5 3 103 memory cells and 104
centroblasts. Therefore, the centroblasts would have to able to analyze three such tonsils. The results from one
are detailed in Figure 4. The lack of viral replication inbe 50% contaminated with memory cells to account for
the signal seen. We conclude, therefore, that both germinal the unfractionated cells is documented in Figure 4A,
which shows the result of a DNA PCR Gardella (Deckercenter populations express the EBNA1(Q-K)1, LMP11,
LMP2a1, EBNA22 phenotype. et al., 1996) analysis. This gel technique allows the linear
form of the virus, indicative of replication, to be resolved
from the episomal form, found in latent infection. TheEBV-Infected Cells Are Absent from the Naive
and Germinal Center Populations in Tonsils viral DNA is detected by DNA PCR. As can be seen in
Figure 4A, only the episomal form of the viral genomethat Lack Infectious Virus
We have shown previously that viral replication is ongo- was detected. Since the DNA PCR can detect a single
copy of the genome (Miyashita et al., 1995), we concludeing in the tonsils. However, in rare tonsils, we found no
Figure 3. EBNA1(Q-K), LMP1, and LMP2a in
the Germinal Center Centroblasts and Germi-
nal Center Centrocytes Are Not Due to Con-
tamination from Memory Cells
(A) Memory cells, germinal center centro-
cytes, and centroblast were purified as de-
scribed in Experimental Procedures and the
legend to Figure 1. RT-PCR analysis was then
performed for EBNA1(Q-K), EBNA2, LMP1,
and LMP2a on serial dilutions of cells for all
four populations. Note, EBNA2 was not de-
tected in any of the populations tested, and
LMP2a was not detected at the highest num-
ber of memory cells tested. For EBNA1(Q-K),
LMP1, and LMP2a, contamination of the or-
der of 50% would be needed of memory into
centroblast or centrocytes to account for the
signals seen. A similar level of contamination
would also be needed of centrocytes into
centroblasts or vice versa to account for the
signals seen.
(B) An example of the positive and negative
controls that were performed for every exper-
iment. Cells from a tonsil that lacked EBV,
based on limiting dilution DNA PCR, were
used as a negative control. The positive control was cells from the Rael cell line for EBNA1(Q-K) and from an EBV lymphoblastoid cell line
for EBNA2, LMP1, and LMP2. The EBV-positive cells were serially diluted into EBV-negative tonsillar cells and used as both a positive control
and a sensitivity control. The cells were analyzed by RT-PCR as described in (A).
(C) FACS reanalysis of the populations used. Cells were isolated as described above. Memory cells and non-B cells would be located in the
bottom left, centroblasts in the top right, and centrocytes in the bottom right quadrants of the dot plots. Therefore, there is #5% contamination
of memory cells in either centroblast or centrocytes, #2.4% contamination of centrocytes in centroblasts, and #1% of centroblasts in
centrocytes.
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stage of the infected B cell. Naive B cells in the tonsil
express the EBNA2-dependent lymphoblastoid growth
program, whereas germinal center and tonsillar memory
cells express a pattern of genes restricted to EBNA1,
LMP1, and LMP2, and peripheral memory cells express
no detectable latent genes, with the exception of LMP2.
The pattern of gene usage agrees well with our model
that EBV needs the lymphoblastoid growth program to
activate the latently infected cells so they can gain ac-
cess, through the normal pathways of germinal center
differentiation, to the memory compartment, the site of
long-term persistence. The ability of the growth program
to drive proliferation, the most striking property of the
virus in vitro, may be of secondary importance to its
ability to activate the cells so they can differentiate.
There are several notes of caution that need to be
taken into account when interpreting these experiments.
Our purification procedures involve multiple fraction-
ation steps and take several hours to complete. This
could affect the integrity of the mRNA within the cells.
However, the tissue where we found the least number ofFigure 4. Tonsils that Lack Viral Replication Also Lack Infected Na-
genes expressed, peripheral memory B cells, was the oneive and Germinal Center Cells
that had the shortest and simplest purification procedure.(A) PCR-modified Gardella gel analysis was performed on purified
Therefore, the complexity of gene expression detectedtonsillar B cells. The Gardella gel allows the episomal and linear
forms of the viral DNA to be fractionated. The episomal DNA mi- was not simply a function of how long the procedure took.
grates more slowly than the linear DNA. The position of the viral The subset where this was of greatest concern was the
DNA is determined by slicing the gel into a series of equal-size germinal center centrocytes, which are known to undergo
pieces and performing DNA PCR on DNA extracted from each slice.
rapid apoptosis in culture (MacLennan, 1994). InstabilitySouthern blot analysis of the PCR products is shown. The migration
of these cells may account for the inconsistent resultspoint of episomal and linear DNA is denoted at the top.
shown in Figure 2, where EBNA1(Q-K) was only found in(B and C) DNA PCR limiting dilution analysis was performed on
naive versus memory and germinal center B cells (B) and on germinal 50% of the samples tested. By testing multiple samples,
center versus memory cells (C) purified from the tonsil shown in (A) we could distinguish whether negative results are real or
above. For details, see Experimental Procedures. The cells were a result of occasional technical difficulties in the assay.
subjected to limiting dilution DNA PCR to estimate the frequency Another possible source of false negatives is that the
of virus-infected cells. Southern blot analysis of the PCR products
absolute sensitivity of the RT-PCR assays is not known.is shown. The absolute number of cells per sample are given to the
We can detect transcripts in a single infected tissueleft. Lanes with experimental samples are labeled with a vertical
culture cell, but the transcript copy numbers in thoseline, positive controls with a plus, negative controls with a minus, and
the molecular weight marker lane with an asterisk. The calculated cells are not known, and the copy number per cell in
frequencies of infected cells for each population are shown in Table vivo may be lower. RT-PCR results also have to be inter-
1, experiment #1. preted with caution because the assay only detects
steady-state levels of mRNA; long-lived mRNA or pro-
teins such as EBNA1 may persist in cells that no longer
that no viral replication is ongoing. Figure 4B shows the transcribe the gene.
limiting dilution DNA PCR analysis on the IgD1 (naive) We do not believe these issues compromise our re-
and IgD2 (mixture of germinal center and memory) cells. sults. LMP1 and LMP2 were detected in all of the tonsil
As shown previously, no infected naive cells are de- subsets; therefore, false negatives are not an issue for
tected when linear viral DNA is absent. Figure 4C shows these mRNAs. Particularly convincing is the inverse
the same analysis carried out after the IgD2 population relationship between the detection of EBNA2 and
was fractionated into the germinal center and memory EBNA1(Q-K). Every tonsil subset tested expressed one or
subfractions. No infected germinal center cells were de- the other but never both. It is difficult to account for this
tected; all of the virus-infected cells were located in the result based on false negatives within a given subset.
memory compartment. The results for all three such We have also performed some RT-PCR assays, when
tonsils are summarized in Table 1 (tonsils five through the sensitivity of all four assays was optimal, on samples
seven). These results can be compared to those in Fig- that contained as few as two infected cells, based on
ure 1A, which shows that the virus is detected in the limiting dilution DNA PCR frequency estimates. Under
germinal center population of tonsils that have infected these circumstances, we have never seen expression of
naive B cells. We conclude, therefore, that in tonsils that latent genes inconsistent with our results, for example,
lack viral replication, naive and germinal center cells are EBNA2 in EBNA1(Q-K)1 populations or vice versa. De-
not latently infected. spite the concerns, therefore, it is apparent that, at the
level of analysis presented here, the patterns of gene
Discussion expression seen were not garbled or random. Defined
patterns of gene expression, consistent with those seen
The studies presented here demonstrate that persistent previously in cell lines and tumors, are seen to be associ-
infection by EBV is characterized by viral gene expres- ated with specific subsets of B cells.
Our experiments are limited to the analysis of stablesion patterns that vary according to the differentiation
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Figure 5. A Diagrammatic Representation of
the Infected Populations Present in the Tonsil
and Peripheral Blood and Their Possible Re-
lationship
Free virus infects naive B cells and drives
them to become proliferating lymphoblasts
expressing the EBNA2-dependent transcrip-
tion program. These cells can differentiate
through a germinal center as centroblasts
and centrocytes that express the HD/NPC
form of latency EBNA1(Q-K)1, LMP11,
LMP2a1, and EBNA22. These cells exit into
the peripheral circulation as resting memory
cells that are transcriptionally quiescent for
viral latent genes. These memory cells recir-
culate through lymph nodes where they un-
dergo reactivation that leads to the reexpres-
sion of the HD/NPC transcription program.
These cells can return to the recirculating
resting state or proceed to replicate the virus.
Differentiation to a plasma cell is a likely can-
didate mechanism for the step marked with
a question mark in the diagram. The key to
the model is that LMP1 and LMP2a are ex-
pressed at the crucial stage where T cell help
and antigen receptor signaling are required
for survival of the B cell; namely, the germinal
center and the memory cell.
The pathway shown in blue only occurs when infectious virus is around and likely represents steps involved in the establishment of the initial
infection. The pathways marked in red occur independently of infectious virus and likely represent the key steps in viral maintenance. The
gray area demarcates events that occur in the tonsillar lymph node.
infection phenotypes found in the tonsil and peripheral received in lymph nodes (Gray and Skarvall, 1988; Lam
et al., 1997). LMP2a and LMP1 can provide these signals;blood; we have not directly addressed the issue of dy-
namic changes in the state of latency of infected cells therefore, the latency program discovered in tonsillar
memory B cells, LMP11, LMP2a1, EBNA1(Q-K)1, couldnor the possibility that other latency states could exist
in other lymphoid tissues. However, certain relation- allow the long-term survival of virus-infected cells within
the recirculating memory compartment.ships can be inferred, based on our experiments and
through analogy to normal B cell biology. A diagram We find no evidence that memory B cells are being
directly infected with EBV. Based on limiting dilutionsummarizing our results within the context of our pro-
posed model is presented in Figure 5. Only naive B cells analysis, we estimate that ,1% of infected memory cells
expresses EBNA2. It is unlikely that memory cells areexpress the growth program, suggesting that they are
the only cells undergoing direct infection with the virus. directly infected and then killed immediately by CTL.
Our assay can detect a single infected cell expressingWe suggest that these cells then turn off EBNA2 so they
can differentiate through a germinal center reaction. EBNA2, and it is not apparent why memory cells would
be killed much more rapidly than naive B cells. In aConsistent with this, infected germinal center cells do
not express the growth program, as they do when di- recent study (Kurth et al., 2000 [this issue of Immunity]),
the immunoglobulin genes have been examined in singlerectly infected in vitro, but a limited transcription pro-
gram, suggesting that they have arisen from another infected cells microdissected from the tonsils of acute
IM patients. Occasional infected naive B cells wereinfected cell type. Since infected germinal center cells
are only detected in the presence of infected naive B found, but the expanding EBNA2-positive clones were
all memory cells. This is consistent with our idea thatcells, we infer that the germinal center cells are derived
from the infected naive cells. The program used by the the infected naive B cells would differentiate rather than
undergo virus-driven expansion. The infected memoryinfected germinal center cells consists of EBNA1, LMP1,
and LMP2. EBNA1 allows retention of the viral genome, cells, on the other hand, being unable to differentiate,
would proliferate until the CTL response arose to destroywhereas LMP1 can provide a surrogate T help signal
(Gires et al., 1997) and LMP2 a surrogate antigen recep- them. Since we have never seen evidence of EBNA2
expression in the memory population of healthy carriers,tor signal (Caldwell et al., 1998). Therefore, this program
is all that is required to rescue the latently infected ger- we interpret the presence of such cells in IM to indicate
that IM is an atypical state where the virus is infectingminal center cells into the memory compartment. We
speculate that all the latent genes may be shut down cells other than the intended target, the naive B cell. This
means that the previous assumption that IM is simply anwhen germinal center cells exit the cell cycle to become
centrocytes so that they can enter the recirculating amplified version of asymptomatic infection (Rickinson
and Kieff, 1996) may be incorrect.memory pool, just as in a normal waning immune re-
sponse. The only transcripts found in the periphery EBV can infect any B cell; therefore, the restriction of
direct infection to the naive subset implies that viralwould be residues from transcription in the lymph nodes.
The long-term survival of memory B cells depends on replication and reinfection must be restricted to regions
of the tonsil where naive B cells predominate, such asT cell help (Gray et al., 1996) and antigen receptor signals
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the mantle zone (Perry and Whyte, 1998). An alternative balanced to produce stable persistent infection is a cen-
origin for the EBNA21 naive cells is that they arose dur- tral question that remains to be answered.
ing the acute stage of infection and have persisted ever
Experimental Proceduressince. This is unlikely because infected naive cells are
not present in tonsils that lack viral replication (Babcock
Primary Cells and Cell Lineset al., 1998). Therefore, the lymphoblastoid naive cells
Namalwa (ATCC), an EBV-positive BL line, was used as a positiveare not self sustaining. The naive subset showed no
control and BJAB, an EBV-negative B cell line, as a negative control
evidence, based on EBNA1(Q-K) expression, that some for DNA PCR studies. An EBV-positive lymphoblastoid cell line was
of the cells were expressing a more restricted form of used as a positive control for RT-PCR of EBNA2, LMP1, and LMP2a.
latency. It is possible that there is a population of naive Rael (gift of Dr. S. Speck), an EBV-positive BL line, was used as a
positive control for EBNA1 (Q-K) RT-PCR. Cells from tonsils thatcells with very limited gene expression, like peripheral
were EBV-negative, by limiting dilution DNA PCR, were used asmemory cells. To achieve this, however, the virus would
negative controls for all RT-PCR experiments and as carrier cellshave to directly infect some naive cells and keep latent
when the cell number tested was less than 2 3 106 cells.
gene transcription silent. It is unclear how this could be Tonsils were obtained from patients undergoing routine tonsillec-
achieved. tomies for obstructed breathing disorders at the Massachusetts
Several investigators have proposed that long-term General Hospital. Tonsillar lymphocytes were prepared as described
previously (Babcock et al., 1998).persistent infection with EBV is associated with expres-
sion of EBNA1 alone from the Q promoter (Masucci and
Magnetic Bead SeparationsErnberg, 1994; Rickinson and Kieff, 1996). However, we
The details of the MACS-based protocol have been described pre-have never found EBNA1(Q-K) expressed alone. Al-
viously (Babcock et al., 1998), except the type of MACS columnthough it is possible that more sophisticated fraction-
used depended on the amount of cells expected in the positive-
ations will dissect out an EBNA1-only latency, we be- bound fraction. For an expected number less than 3 3 107 total
lieve it is more likely that EBNA1 will always be positive cells, the AS column (Miltenyi Biotec) was used, and for
expressed along with LMP1 and LMP2a. Germinal cen- expected numbers greater than 3 3 107 but less than 2 3 108 total
positive cells, the CS column was used. All antibodies were titratedter centroblasts, germinal center centrocytes, and mem-
for optimal recovery and purity of the desired population. Theory cells all express EBNA1(Q-K) with LMP1 and LMP2.
amounts of biotinylated antibody added were 0.060 mg of aIgDWe believe this is because they provide the signaling
antibody (Southern Biotechnology), 0.072 mg of aCD19 (our lab),functions necessary to rescue both germinal center B
and 0.03 mg of aCD3 (Pharmingen). A typical MACS separation
cells into memory and to maintain latently infected mem- takes about 3 hr; all operations were performed at 408C.
ory cells within the memory compartment. It now seems
likely that this program is expressed in tumors because FACSort Separations
it is the default transcription program that the virus uses Due to the a lack of biotinylated antibodies for markers of germinal
center B cells, the FACSort, in conjunction with fluorochrome-to promote the survival of latently infected cells. For this
labeled antibodies, was employed. First, IgD2 B cells were purifiedreason, we propose that this form of latency be referred
using the MACS system, as described above, by negative selectionto as the default or survival program to contrast with
for CD3 and IgD. Given that tonsils contain ,1% monocytes, thisthe growth program of the proliferating lymphoblasts
typically yielded .80% purity in the negative fraction for IgD2 B
and the latency program of the quiescent recirculating cells. For separation of CD101 B cells in tonsil, cells were stained
memory cells. with PE-coupled aCD10 (1:50) (Pharmingen) and FITC-coupled aIgD
Recent claims that transgenic expression of LMP1 (1:500), and the CD101, IgD2 B cells were sorted. For purification
of centroblasts and centrocytes, CD77 was used as a marker. CD77blocks germinal center formation are contradictory to
is expressed on centroblasts but not centrocytes. Cells were firstour model (Uchida et al., 1999). However, the failure to
stained with unconjugated aCD77 antibody (Immunotech) at a 1:100develop germinal centers may be an artifact of constitu-
dilution and washed. The cells were then stained with FITC-coupledtive expression of LMP1 from the transgene, since the
arat IgM (Jackson Labs) at a 1:20,000 dilution and PE-coupled
mice had other abnormalities, as evidenced by the de- aCD10. The CD771, CD101 centroblasts and CD772, CD101
velopment of lymphomas. Interestingly, the B cells were centrocytes were then sorted. A typical FACS separation could take
able to undergo isotype switching, raising the possibility up to 6 hr. All operations were performed at 408C.
that EBV-driven lymphoblasts might differentiate into mem-
ory without developing identifiable germinal centers. FACS Analysis and Antibodies
Flow cytometric analysis was used to assay the purity of all isolatedIf our model is correct, then EBV latency consists of
populations. In all experiments, the purified population was $90%continuous infection and proliferation followed by ger-
pure and frequently .95% pure for the desired marker, with #5%minal center differentiation into memory cells that in
contamination by any undesired B cell subset. The remaining con-turn undergo periodic activation and expansion. The
tamination consisted of T cells, which lack EBV and are therefore
countervailing force is the immune response. Poten- irrelevant to the analysis. Based on these results, we made the
tially, every step in the pathway is a target for regulation conservative assumption that we cannot be sure of the status of
by the immune response (Thorley-Lawson and Poodry, virus infection in any subset where the estimated frequency of virus-
infected cells could be accounted for by #10% contamination with1982; Khanna et al., 1992; Bogedain et al., 1995), with
another B cell subset.the possible exception of the peripheral memory cells.
All fractionated populations were analyzed using a Becton Dickin-Why doesn’t the immune system either clear the infec-
son FACScan with Lysis II software as described previously (Bab-tion or the memory compartment steadily fill up with cock et al., 1998).
latently infected cells? Since the memory cells are quies-
cent and express minimal if any viral genes, their DNA PCR and Limiting Dilution DNA PCR
numbers may be regulated by the same counting mech- Limiting dilution DNA PCR analysis was performed on isolated popu-
anisms that regulate homeostasis in the memory com- lations exactly as described previously (Babcock et al., 1998). Cell
populations were serially diluted, and multiple samples of each dilu-partment. Exactly how all these competing forces are
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tion were tested by DNA PCR. Serial dilutions were never performed Jainandunsing, S., Bergthorsdottir, S., and Dullforce, P. (1996).
B-T lymphocyte interactions in the generation and survival of mem-on cell extracts or isolated DNA.
ory cells. Immunol. Rev. 150, 45–61.
RT-PCR Khanna, R., Burrows, S.R., Kurilla, M.G., Jacob, C.A., Misko, I.S.,
RNA was purified from 5 3 106 cells with Trizol (GIBCO), as described Sculley, T.B., Kieff, E., and Moss, D.J. (1992). Localization of Epstein-
by the manufacturer. If necessary, lymphocytes from an EBV-nega- Barr virus cytotoxic T cell epitopes using recombinant vaccinia:
tive tonsil were added to samples to bring the cell number up to implications for vaccine development. J. Exp. Med. 176, 169–176.
5 3 106. cDNA was prepared as described previously (Babcock et Khanna, R., Burrows, S.R., and Moss, D.J. (1995). Immune regulation
al., 1998), except the 20 ml cDNA mixture was not ethanol precipi- in Epstein-Barr virus-associated diseases. Microbiol. Rev. 59,
tated but brought up to 100 ml with HPLC H2O and used directly. 387–405.
The cDNA suspension (20 ml) was aliquoted to 200 ml Microamp
Kieff, E. (1996). Epstein-Barr virus and its replication. In Virology,reaction tubes, and PCR was carried out in a final volume of 50 ml
B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (New York: Ravenconsisting of 50 mM KCl, 20 mM Tris (pH 8.4), 2.5 mM MgCl2, 0.2
Press), pp. 2343–2396.mM dNTPs, and 20 pM each of the amplimers (3.0 mM MgCl2 was
Kuppers, R., and Rajewsky, K. (1998). The origin of Hodgkin andused for LMP1). This allowed RT-PCR to be performed for all four
Reed/Sternberg cells in Hodgkin’s disease. Annu. Rev. Immunol.latent genes from one cDNA pot. The amplimers were EBNA1(Q-K),
16, 471–493.TGGCCCCTCGTCAGACATGATT and AGCGTGCGCTACGGAT;
EBNA2, CATAGAAGAAGAAGAGGATGAAGA and GTAGGGATTCG Kurth, J., Spieker, T., Wustrow, J., Strickler, J.G., Hansmann, M.-L.,
AGGGAATTACTGA (Qu and Rowe, 1992); LMP1, TTGGTGTACTC Rajewsky, K., and Ku¨ppers, R. (2000). Tracing EBV-infected B cells
CTACTGATGATCACC and AGTAGATCCAGATACCTAAGACAAGT in infectious mononucleosis: viral strategies for spreading in the B
(Qu and Rowe, 1992); and LMP2a, ATGACTCATCTCAACACATA and cell compartment and establishment of latent infection. Immunity
CATGTTAGGCAAATTGCAAA (Qu and Rowe, 1992). Reactions were 13, this issue, 485–495.
incubated at 958C for 5 min, and 1 U of Taq DNA Polymerase (Perkin Lam, K.P., Kuhn, R., and Rajewsky, K. (1997). In vivo ablation of
Elmer) was added to each tube. The tubes were loaded in a Gene- surface immunoglobulin on mature B cells by inducible gene tar-
amp 9600 thermocycler, and the following conditions were run: for geting results in rapid cell death. Cell 90, 1073–1083.
EBNA1 (Q-K) and EBNA2, 958C for 15 s, 628C for 30 s, and 728C for
Liu, Y.J., and Arpin, C. (1997). Germinal center development. Immu-30 s, repeated for 40 cycles; LMP1, 958C for 15 s, 658C for 30 s,
nol. Rev. 156, 111–126.and 728C for 30 s, repeated for 40 cycles; and LMP2a, 958C for 15
MacLennan, I.C. (1994). Germinal centers. Ann. Rev. Immunol. 12,s, 558C for 30 s, and 728C for 1 min, repeated for 40 cycles. All PCRs
117–139.were concluded with a 5 min incubation at 728C to complete the
extension of all synthesized products. PCR products were visualized Masucci, M.G., and Ernberg, I. (1994). Epstein-Barr virus: adaptation
by Southern blotting as described above. Blots were probed using to a life within the immune system. Trends Microbiol. 2, 125–130.
PCR product derived from the IB4 or Rael cell lines. Miyashita, E.M., Yang, B., Lam, K.M., Crawford, D.H., and Thorley-
Lawson, D.A. (1995). A novel form of Epstein-Barr virus latency in
Gardella Gel Analysis normal B cells in vivo. Cell 80, 593–601.
PCR-modified Gardella gel analysis was performed as previously
Miyashita, E.M., Yang, B., Babcock, G.J., and Thorley-Lawson, D.A.described (Decker et al., 1996).
(1997). Identification of the site of Epstein-Barr virus persistence in
vivo as a resting B cell. J. Virol. 71, 4882–4891.
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